Tokyo, Japan

Satoru Kaifuchi

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Hirotsu Bio Science Inc.. Active years: 2021-2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Satoru Kaifuchi: Innovator in Cancer Examination Methods

Introduction

Satoru Kaifuchi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of veterinary medicine, particularly in the examination of cancer in pet animals. With a total of 2 patents, his work is paving the way for innovative diagnostic methods.

Latest Patents

Kaifuchi's latest patents include a method for examining cancer in pet animals. This method involves evaluating the taxic behavior of nematodes toward a urine sample from a subject mammal. His second patent focuses on evaluating the taxic behavior of nematodes in response to odor substances based on their olfactory sense. This method includes a specific setup where nematodes are arranged in proximity to a test sample, allowing for observation of their attraction or avoidance behavior.

Career Highlights

Satoru Kaifuchi is currently associated with Hirotsu Bio Science Inc., where he continues to develop innovative solutions in the field of veterinary diagnostics. His work is instrumental in enhancing the accuracy of cancer detection in non-primate mammals.

Collaborations

Kaifuchi collaborates with notable colleagues such as Takaaki Hirotsu and Takayuki Uozumi. Their combined expertise contributes to the advancement of research and development in their respective fields.

Conclusion

Satoru Kaifuchi's innovative approaches to cancer examination in pet animals highlight his commitment to improving veterinary diagnostics. His contributions are significant in the ongoing quest for better health solutions for animals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…